Skip to main content

Global Melatonin Market to Surpass USD 1032.54 million by 2030 Driven by Rise in Insomnia

SkyQuest projects that the global melatonin market will attain a value of USD 1032.54 million by 2030, with a CAGR of 11% during the forecast period (2023-2030). Increased disposable income due to technology and globalization, increasing number of employed workers is one of the main reasons for the rise in insomnia in recent times. This is due to lifestyle and unhealthy diet leading to increased sodium intake and factors that directly or indirectly increase blood pressure. Generating these will drive the demand for melatonin supplements to reduce stress and insomnia which will drive the global melatonin market during the research period.

Westford, USA, Feb. 29, 2024 (GLOBE NEWSWIRE) — Strict regulations and standards regarding the use and packaging of OTC and over-the-counter drugs are the major restraining factors that can retard the growth of the global melatonin market during the analyzed period.

Browse in-depth TOC of “Melatonin Market”

●       Pages – 260
●       Tables – 89
●       Figures – 76

Low levels of melatonin can lead to anxiety and sleep problems in the global melatonin market. It is possible that using melatonin supplements will help you sleep better. Some blood pressure medications interfere with sleep. Oral melatonin can help patients taking beta-blockers sleep better and drive market growth.

Get a sample copy of this report:

https://www.skyquestt.com/sample-request/melatonin-market

Prominent Players of Global Melatonin Market

  • Life Extension
  • Pharmavite LLC
  • NBTY Inc.
  • Kirkland Signature (Costco Wholesale Corporation)
  • Puritan’s Pride (International Vitamin Corporation)
  • GNC Holdings Inc.
  • Solgar Inc.
  • Douglas Laboratories
  • Webber Naturals Inc.
  • Source Naturals LLC
  • Sundown Naturals (NBTY Inc.)
  • Life Brand (Shoppers Drug Mart Corporation)
  • The Vitamin Shoppe
  • Schiff Nutrition International Inc.
  • Biotics Research Corporation
  • Garden of Life LLC
  • Jarrow Formulas Inc.

Natural Segment to Dominate Market Owing to Rising Natural Properties

Natural melatonin dominates the segment with the largest market share in the global melatonin market and is predicted to continue to do so during the forecast period. Natural melatonin has natural properties, and is recommended by doctors for relaxation, jetlag and rapid eye movement, among other things.

By 2022, the North America region will dominate the global melatonin market with a dominant market and revenue share. Growing problem of insomnia in developed countries due to lifestyle problems and diet is a major reason for the rise in demand for melatonin in United States and Canada and will drive the growth of melatonin market in this region. During the analyzed period, it will drive the growth of the global melatonin market in the North America region.

Browse summary of the report and Complete Table of Contents (ToC):

https://www.skyquestt.com/report/melatonin-market

Synthetic Segment to Witness Significant Growth Owing to Rise in Medication Consumption

The Food and Drug Administration (FDA) examines synthetic melatonin as a supplement, not a drug. As a result, melatonin can be found in drugstores and natural food stores. These medications are available in tablet, liquid, chewable, or lozenge form. According to experts, long-term synthetic melatonin is safe in the global melatonin market.

Asia Pacific is expected to exhibit significant growth during the forecast period due to increasing technology and changing lifestyle and dietary habits due to increase in disposable income in developing countries are major contributing factors insomnia is increasing hence the following reasons will drive the demand for melatonin in the region and that will boost the growth of global melatonin market during the analyzed period.

A comprehensive analysis of the major players in the global melatonin market has been recently conducted in this report. The report encompasses various aspects, including collaborations, mergers, innovative business policies, and strategies, providing valuable insights into key trends and breakthroughs in the market. Furthermore, the report scrutinizes the market share of the top segments and presents a detailed geographic analysis. Lastly, the report highlights the major players in the industry and their endeavors to develop innovative solutions to cater to the growing demand.
Speak to Analyst for your custom requirements:

https://www.skyquestt.com/speak-with-analyst/melatonin-market

Key Developments of Global Melatonin Market

  • In August 2022, Pfizer Inc. and Global Blood Therapeutics, Inc. announced today that it has signed a U.S. deal. $5.4 billion to acquire Pfizer GBT, a life-changing biopharmaceutical company dedicated to developing hope-inspiring therapies for underserved patient groups, beginning with sickle cell disease (SCD).
  • In October 2023, Nutraland USA, Inc., a leading manufacturer of natural sustainable products, shared the announcement of the release of Somato™, a special melatonin extract made from tomatoes Those new products this yield poorer quality and more natural products compared to synthetic melatonin. It is expected to lead to a major revolution in product development, for use in foods and pharmaceutical additives ho aimed at improving health.

Key Questions Answered in Global Melatonin Market Report

  • What specific growth drivers are projected to impact the market during the forecast period?
  • List the top companies in the market and explain how they have achieved their positions of influence.
  • In what ways do regional trends and patterns differ within the global market, and how do these differences shape the market’s future growth?

Related Reports in SkyQuest’s Library:

Global Neurosurgery Market

Global Paresthesia Treatment Market

Global Neonatal Intensive Care Market

Global Recombinant Vaccines Market

Global Bacterial Cell Culture Market

About Us:

SkyQuest Technology is leading growth consulting firm providing market intelligence, commercialization and technology services. It has 450+ happy clients globally.

Address:

1 Apache Way, Westford, Massachusetts 01886

Phone:

USA (+1) 617-230-0741

Email: sales@skyquestt.com

LinkedIn Facebook Twitter

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.